Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001019056-20-000239

Options or other derivatives

  • SVP, Commercial Operations acquired 134,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Adelman Michael SVP, Commercial Operations 2020-02-18 Grant or award · Stock Option (right to buy) +134,800 134,800 D
Loading xslF345X03/adelman.xml…